Photo: academy.eahad.org
May 1, 2026, 13:23
EAHAD 2025 Von Willebrand Disease Insights Now Available On EAHAD Academy
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
”A century of progress in von Willebrand Disease continues to shape how we diagnose, understand, and treat patients today.
At EAHAD 2025, this session featured Carlo Castaman, Omid Seidizadeh, and Jeroen Eikenboom to explore key advances across the full spectrum of VWD.
Missed the live session? Relive the insights anytime on EAHAD Academy.”
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared this post on LinkedIn, adding:
”It was my pleasure to be invited to contribute to this EAHAD session on von Willebrand Disease.”
Stay updated with Hemostasis Today.
-
May 1, 2026, 13:17Ivan Tesakov: Unraveling Platelet Dysfunction in ETV6-Related Thrombocytopenia
-
May 1, 2026, 12:59Tewahido Haymanot: Did You Know that Lab Result Quality Starts Before the Analyzer?
-
May 1, 2026, 12:49Yusuf Wardak: Endovascular Therapy Improves Quality of Life in Proximal Lower Limb DVT
-
May 1, 2026, 12:34A New Era in Hemophilia A Management with Clinical Insights on Mim8 – NEJM Group
-
May 1, 2026, 12:31Dave Cartland: Autoimmune Factor V Deficiency After mRNA Vaccination at Dialysis Initiation
-
May 1, 2026, 12:24Chandrasekhar Bendi: Aplastic Anemia – Understanding a Rare but Serious Blood Disorder
-
May 1, 2026, 12:23Ceasovschih Alexandr: A New Perspective on Allergic Cardiac Events Driven by Host Factors
-
May 1, 2026, 12:08Paolo Zamboni։ Endothermal Ablation Alone Is Not Enough for Optimal Results
-
May 1, 2026, 11:59Stamatis Karakatsani: Immune Cells and Platelets in Blood Clot Formation